Latest News

• Int'l webcast on enhancing blood pressure control held - Philippine Star
  

  Int'l webcast on enhancing blood pressure control heldPhilippine StarAmlodipine + valsartan + hydrochlorothiazide works in different ways to lower blood pressure.

• Shanghai to acquire major stake in Changzhou Kony - Pharmaceutical Business Review
  

  In-PharmaTechnologist.

• Novartis earnings fall 47% but pleased with pipeline - Pharma Times
  

  Kansas City StarNovartis earnings fall 47% but pleased with pipelinePharma TimesNovartis' biggest-seller was once again the blood pressure lowerer Diovan (valsartan), though sales were down 16% to $1.

• Novartis cuts nearly 2000 jobs in USA, takes major charges - Pharma Times
  

  The Boston GlobeNovartis cuts nearly 2000 jobs in USA, takes major chargesPharma TimesThe restructuring was prepared to respond to the loss of Diovan (valsartan) expected in the USA in September 2012.

• Takeda gains approval for hypertension drug Azilva in Japan - PMLiVE
  

  Takeda gains approval for hypertension drug Azilva in JapanPMLiVEAzilva (azilsartan medoxomil) is a late entrant into the crowded angiotensin receptor blocker (ARB) category, which has already seen some lead drugs in the category, including losartan and valsartan, lose patent protection and face generic competition.